SUMMARY-Antibody titers for viral capsid antigens of all four human herpesviruses were measured by immunofluorescence in the sera of 16 Burkitt's lymphoma (BL) patients, 16 age-, sex-, and locality-matched controls, and 136 family members from the West Nile District of Uganda. Among family members, titers greater than 1:4 were found in 98% for herpes simplex virus (HSV), 86% for varicella-zoster virus (V2V), 100% for cytomegalovirus (CMV), and 94% for Epstein-Barr virus (EBV). Titers in patients averaged 2 logs (fourfold) higher than those in matched controls for EBV, VZV, and CMV (P=0.001); titers for HSV were only slightly higher in cancer patients. The mothers of patients had somewhat higher EBV titers (0.05<P<0.01) than the mothers of controls, but no other differences between patient and control families were found. By immunofluorescence, a method which apparently has not been used for all four human herpesviruses in BL patients, the patients had elevated antibody titers not only to EBV but also to CMV and VZV. The elevated titers to three of the four human herpesviruses were not due to serologic cross reactions. In a recent field study in \Vest Nile, Uganda (9), the clinical histories of many BL patients suggested that herpes simplex infection had occurred shortly before onset of the tumor. FA titers for herpes simplex virus (HSV), varicella-zoster virus (VZV ), cytomegalovirus (CMV), and EBV were therefore measured in sera from the patients with BL and from controls and their families. Not only EBV but also CMV and VZV titers were higher in patients than in controls.
HIGH TITERS OF ANTIBODY to Epstein-Barr virus (EBV) were found by the fluorescent antibody (FA) test in a high percentage of Burkitt's lymphoma (BL) patients (1, 2) , and EBV is involved in most etiologic hypotheses about BL (2) (3) (4) (5) . Few serologic studies of other herpesviruses were reported in BL patients (6, 7) , and apparently none measured antibodies to all four viruses by the indirect ininittnofluorescent method (1, 8) .
In a recent field study in \Vest Nile, Uganda (9), the clinical histories of many BL patients suggested that herpes simplex infection had occurred shortly before onset of the tumor. FA titers for herpes simplex virus (HSV), varicella-zoster virus (VZV ), cytomegalovirus (CMV), and EBV were therefore measured in sera from the patients with BL and from controls and their families. Not only EBV but also CMV and VZV titers were higher in patients than in controls.
MATERIALS AND METHODS
Sera were collected in \Vest Nile from 16 BL patients, from 16 controls of the same age and sex, and from 136 other individuals in patient and control families. Controls were selected by random numbers from tax lists in the same subcounty as the patients (9). Blood specimens were allowed to clot before overnight storage at 4° C. The sera were stored at -20° C and then placed in liquid nitrogen for shipment and further storage.
Antibody to EBV was tested at the IARC with standard methods for the viral capsid antigen (VCA) test (1, 8) and fourfold serum dilutions beginning at 1:10. Antibody against the other three viruses was measured at The Netherlands Cancer Institute by a similar indirect immunofluorescence method (10) with a 1:40 dilution of fluorescein-conjugated swine antihuman immunoglobulin obtained from Nordic, Tilburg, The Netherlands (in preparation). The antigens were as follows: HSV type-2 obtained from a vaginal specimen and grown in RK13 cells; VZV (isolate 69-115) from a zoster patient, grown in diploid human embryonic lung fibroblasts; and a CMV isolate, "Reints," grown in the same strain of cells. The VZV and CMV strains were provided by Dr. K. W. Slaterus, Wilheinina Gasthuis, Amsterdam, The Netherlands, who identified them by their cytopathology and reactions with known antisera in complement-fixation tests. Infected cells were mixed with an equal number of uninfected cells before being applied to the microscope slides, dried overnight, and then fixed in acetone for 10 minutes before storage at -20° C. Sera were diluted in fourfold steps beginning with 1:4. HSV type-1 and -2 gave similar results in this test, and a single antigen (type-2) was therefore used for convenience. Patient and control sera identified only by number were tested together; the clinical histories were unknown to those performing the test.
RESULTS
All patients and controls had titers of 1:16 or more to HSV and CMV and 1:10 or more to EBV (1 of the 16 patients was not tested for EBV). Two patients and five controls had no titer (<4) against VZV; the others had titers of 1:4 or above. Table 1 indicates the geometric mean titers (GMT) of all groups tested. Titers were =4 times (2 logs) higher in patients than in controls for VZV, CMV, and EBV (table 2). The differences were statistically significant at the Pc-, 0.001 level for all three by the Student's t-test. HSV titers were slightly higher in patients than in controls. The mothers of patients had higher titers for EBV than the mothers of controls. In case and control families, statistically significant titer differences were found only between cases and their controls, not between their mothers, fathers, and siblings, and the differences were almost equal in magnitude for VZV, CMV, and EBV. FA titers for all four human herpesviruses in a group of BL patients and controls. The elevation of CMV and VZV titers and those for EBV suggests that testing of other serum collections with the FA technique might produce valuable information and shed some light on the meaning of a "high" titer to a herpesvirus-the central unanswered question which underlies EBV serology.
Our results might be due to chance, to variability of the FA test, or to factors peculiar to the ecology of West Nile. FA tests in the EBV field have shown that variability up to two or even three dilutions can be obtained from one testing to another, depending, among other factors, on the antigen batch (type of cell line and proportion of immunofluorescent cells) (19) . When CMV, VZV, and HSV antibodies were tested, similar variability was observed. However, the titers were obtained in tests in which coded patient and control sera were intcrdigitatcd and the sera were from a small but carefully matched series of cases and controls. The elevation of FA titers for VZV, CMV, and EBV can be looked for in larger groups of BL patients and controls and by other laboratories.
Cross-reactions among the human herpesviruses in the FA test could produce high titers to several viruses in the same serum. Other workers have not found years and under, in control families tested the crossreaction hypothesis. The titer for each virus was plotted against the titer of one of the other three viruses in the same scrum. The results for each possible pair of viruses showed a complete scatter; there was no evidence of relationship between a high titer for one virus and high or low titers for any of the others. For each possible pair of viruses, sera could be found with high titers for one virus (HSV-256, VZV-128, EBV-160, ,CMV-512) which had low titers for the other (HSV and VZV-4, EBV-10, CMV-32). Finally, 20 sera from patients with nasopharyngeal carcinoma and 20 controls, which were tested by our laboratories together with the present BL series with the same antigens, showed highly elevated titers for EBV but not for the other human herpesviruses. These findings have been extended and will be reported separately (in preparation). Serologic cross-reaction does not seem a reasonable explanation of the findings. herpetic-type lesions have healed by the time the patients came to the hospital, it was impossible to attempt isolation of HSV from these lesions; it was hoped that serology would yield clues about the cause of the oral ulcers and unilateral conjunctivitis described by the patients (9). However, since all the patients had HSV titers of 1:64 or higher and all the controls had titers of I :16 or more, HSV infection can neither be ruled in nor out. Patients with a history of herpes-like lesions did not have higher HSV titers than did controls or the other patients. Douglas and Couch (22) showed, however, that patients with recurrent herpes infections do not necessarily have high neutralizing antibody titers or rises in titer with recurrences, and there is no reason to believe that FA titers would be different in this regard. Hence the failure to find "elevated" HSV titers in our BL patients does not prove or disprove the clinical hypothesis of an association between BL and HSV.
The hypothesis that the tumors arc caused by an interaction between EBV and another herpesvirus would be difficult to test in a population in which nearly everyone is infected by several herpcsviruses at an early age.
The association between BL and EBV is not only supported by scrocpidcmiologic data, but also by the regular presence in African BL tumor cells of EBV fingerprints, i.e., EBV genomes (23, 24) and EBV-specific nuclear antigen (25). The presently reported FA titers for other herpcsviruses should be completed by other tests directed against early antigen, membrane antigen, and soluble antigen of CMV, VZV, HSV-I, and HSV-2. BL biopsy specimens should be examined for virus genomes other than EBV. The on going prospective seroepidentiologic study of BL in the West Nile district of Uganda (26) would provide the proper material from BL cases and controls to perform such scrocpidemiolgic and molecular virologic studies.
